Eagle Meds Services
Xadago (safinamide mesylate)
Available to sourceHuman Prescription DrugOncology & Specialty

Xadago (safinamide mesylate)

100 mg/1 · Film-Coated Tablet
By MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
NDC
27505-111
Route
Oral
Therapeutic class
Breast Cancer Resistance Protein Inhibitors [MoA], Monoamine Oxidase Type B Inhibitor , Monoamine Oxidase-B Inhibitors [MoA]
Marketing category
NDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
Xadago (safinamide mesylate)
NDC 27505-111
(980) 480-3410 requests@eaglemedsservices.com

Related in Oncology & Specialty

See all →
Verzenio (abemaciclib)

Verzenio (abemaciclib)

50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

150 mg/1 · Tablet
Eli Lilly and Company
Available to source